Russell Investments Group Ltd. Reduces Holdings in Kenvue Inc. $KVUE

Key Points

• Russell Investments Group Ltd. reduced its holdings in Kenvue Inc. by 5.5%, owning approximately 1.44 million shares valued at about $34.6 million after selling 83,894 shares in the 1st quarter.
• Kenvue reported earnings per share of $0.29 for the quarter, exceeding analysts' expectations, but its revenue of $3.84 billion fell short of the anticipated $3.94 billion.
• The company declared a dividend increase to $0.2075 per share, resulting in an annualized yield of 3.9% and raising the payout ratio to 112.16%.

Russell Investments Group Ltd. cut its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 5.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,443,698 shares of the company's stock after selling 83,894 shares during the quarter. Russell Investments Group Ltd. owned 0.08% of Kenvue worth $34,596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Prudential PLC grew its position in Kenvue by 21.2% during the first quarter. Prudential PLC now owns 695,816 shares of the company's stock valued at $16,686,000 after acquiring an additional 121,673 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock valued at $39,000 after purchasing an additional 1,287 shares during the period. Resona Asset Management Co. Ltd. increased its stake in shares of Kenvue by 12.8% in the first quarter. Resona Asset Management Co. Ltd. now owns 717,073 shares of the company's stock worth $17,144,000 after buying an additional 81,300 shares during the period. Trajan Wealth LLC boosted its position in Kenvue by 119.6% during the 1st quarter. Trajan Wealth LLC now owns 450,196 shares of the company's stock valued at $10,796,000 after buying an additional 245,230 shares during the period. Finally, Public Sector Pension Investment Board increased its position in shares of Kenvue by 8.6% in the first quarter. Public Sector Pension Investment Board now owns 260,416 shares of the company's stock valued at $6,245,000 after acquiring an additional 20,517 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Kenvue Stock Performance

Kenvue stock traded up $0.3760 during trading on Tuesday, reaching $21.4760. The company had a trading volume of 2,969,904 shares, compared to its average volume of 17,476,414. The firm has a market capitalization of $41.21 billion, a price-to-earnings ratio of 29.01, a price-to-earnings-growth ratio of 3.05 and a beta of 0.83. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The firm's 50-day simple moving average is $21.54 and its 200 day simple moving average is $22.43. Kenvue Inc. has a 52 week low of $19.75 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. During the same quarter in the prior year, the business posted $0.32 earnings per share. The business's quarterly revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th will be given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 3.9%. The ex-dividend date is Wednesday, August 13th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is 112.16%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Zacks Research upgraded Kenvue to a "strong sell" rating in a research report on Monday, August 11th. Bank of America lowered their price objective on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, July 15th. Citigroup decreased their target price on Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a research report on Tuesday, July 15th. Barclays decreased their price objective on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, July 15th. Finally, Royal Bank Of Canada reduced their target price on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research report on Friday, August 8th. Five investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $24.38.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.